Multicenter Infection Surveillance Study Following Colorectal Procedures
MISS
Phase IV Multicenter Infection Surveillance Study Following Colorectal Procedures
1 other identifier
observational
289
0 countries
N/A
Brief Summary
This study is a multicenter, open label, observational, postmarketing surveillance study of the ON-Q® Silver SoakerTM in the United States and Canada. This study was developed to investigate specific aspects of infection rates and hospital length of stay following routine use of this device in patients undergoing colorectal surgical procedures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2006
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2007
CompletedFirst Submitted
Initial submission to the registry
September 29, 2008
CompletedFirst Posted
Study publicly available on registry
September 30, 2008
CompletedMarch 19, 2015
December 1, 2014
9 months
September 29, 2008
March 17, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Surgical site infection
30 days postoperative
Secondary Outcomes (1)
Hospital length of stay
Average 1 week
Study Arms (2)
Active
Surgical site continuous local anesthetic infusion with ONQ silver Soaker System
Control
Hospital standard of care for pain management (Patient controlled analgesia or epidural)
Interventions
Continuous infusion of local anesthetic to surgical site
Eligibility Criteria
Surgical patients Colorectal procedures
You may qualify if:
- Men and women, \>18 years of age;
- Scheduled for elective colon procedure;
- Ability to complete patient survey questionnaires;
- Provision of informed consent
You may not qualify if:
- Patients with a prior allergic reaction to Morphine, Demerol, Dilaudid, Fentanyl, Marcaine (bupivacaine), lidocaine or Naropin (ropivacaine);
- Procedures for hemorrhoids;
- Inability to perform follow up assessments
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Halyard Healthlead
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jay Singh, MD
Piedmont Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 29, 2008
First Posted
September 30, 2008
Study Start
November 1, 2006
Primary Completion
August 1, 2007
Study Completion
September 1, 2007
Last Updated
March 19, 2015
Record last verified: 2014-12